Formulation and Evaluation of Elastic Liposomes of Decitabine Prepared by Rotary Evaporation Method

Abstract

Decitabine is a cytidine deoxynucleoside analog, which acts by inhibiting DNA methyltransferase, and is used for the treatment of acute myeloid leukemia. Decitabine has a short half-life (25 minutes), and is sensitive to harsh conditions. Elastic liposomes are an effective tool that can be used to overcome this disadvantage. Elastic liposomes also known as transfersomes are modified lipid carriers that enable drug to reach deeper skin layers and/or the systemic circulation. These vesicular formulations are several orders of magnitudes, more deformable than the standard liposomes and thus well suited for skin penetration. The objective of present study is to develop and evaluate the elastic liposomes of Decitabine so as to provide the sustained release and improve its bioavailability. Elastic liposomes were prepared by rotary evaporation method using Span 80 and Span 60 as a surfactants. The prepared Elastic liposomes were evaluated for entrapment efficiency, vesicle size, in vitro drug release. The drug release profiles from different elastic liposomes-in-vehicle formulations were in agreement with the physicochemical properties of the formulations. Based on different parameters formulations of batch ELS1 was found to be the best formulations. Stability study was performed on the selected formulation ELS1. Study concludes that Decitabine can also be formulated in the liposomal carrier which finds its best way for the topical administration.

Transdermal patches: updated review as a novel drug delivery system

“…An inverted funnel is positioned above the petri dish to control the solvent's rate of evaporation. The films that have dried out must be kept in a desiccator [15][16][17][18].…”

A comprehensive review on liposomes: A vesicular system for drug delivery

“…500 ml 20% ethanol was used as the release medium; 10 ml release medium was drawn and placed into a dialysis bag The dialysis bag was then clamped and attached on the paddle of a dissolution apparatus; 5 ml drug-containing liposomes and 5 ml ethanol solution of drug with the same drug content as the liposomes, were respectively dissolved in the dialysis vessel, with stirring at 37°C and 300 × g. A sampling of 100 μl liquid from the dialysis bag was conducted at 1, 2, 4, 6, 8, 10, 12 and 24 h for sample determination and calculation of the accumulative release rate. A release curve was drawn using the time (t) [28].…”

Formulation and Evaluation of Aceclofenac Liposomes

“…This delivery system is used in study because of their specialized characteristics and helps to incorporate the Aceclofenac efficiently and used as topically and ultimately reduce the oral side effects of Aceclofenac. 9 ISSN: 2250-1177…”